115. Sheldon R, Connolly S, Krahn A, Roberts R, Gent M, Gardner M. Identification of
patients most likely to benefit from implantable cardioverter-defibrillator therapy:
the Canadian Implantable Defibrillator Study. Circulation 2000;101:1660-4.
116. Connolly SJ, Hallstrom AP, Cappato R, et al. Meta-analysis of the implantable
cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS
studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study
Hamburg . Canadian Implantable Defibrillator Study. Eur Heart J 2000;21:2071-8.
117. Healey JS, Hallstrom AP, Kuck KH, et al. Role of the implantable defibrillator
among elderly patients with a history of life-threatening ventricular arrhythmias.
Eur Heart J 2007;28:1746-9.
118. Mark DB, Nelson CL, Anstrom KJ, et al. Cost-effectiveness of defibrillator therapy
or amiodarone in chronic stable heart failure: results from the Sudden Cardiac
Death in Heart Failure Trial (SCD-HeFT). Circulation 2006;114:135-42.
119. Sanders GD, Hlatky MA, Owens DK. Cost-effectiveness of implantable
cardioverter–defibrillators. N Engl J Med 2005;353:1471-80.
120. Bryant J, Brodin H, Loveman E, Clegg A. Clinical effectiveness and cost-
effectiveness of implantable cardioverter defibrillators for arrhythmias: a systematic
review and economic evaluation. Int J Technol Assess Health Care 2007;23:63-70.
121. Cram P, Katz D, Vijan S, Kent DM, Langa KM, Fendrick AM. Implantable or
external defibrillators for individuals at increased risk of cardiac arrest: where cost-
effectiveness hits fiscal reality. Value Health 2006;9:292-302.
122. Buxton M, Caine N, Chase D, et al. A review of the evidence on the effects and
costs of implantable cardioverter defibrillator therapy in different patient groups,
and modelling of cost-effectiveness and cost-utility for these groups in a UK
context. Health Technol Assess 2006;10:iii-iv, ix-xi, 1-164.
123. Caro JJ, Ward A, Deniz HB, O'Brien JA, Ehreth JL. Cost-benefit analysis of
preventing sudden cardiac deaths with an implantable cardioverter defibrillator
versus amiodarone. Value Health 2007;10:13-22.
124. Ribeiro RA, Stella S, Rohde LE, Pimentel M, Zimerman L, Polanczyk C. Custo-
efetividade de desfibriladores implantáveis no Brasil: análise em prevenção